These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1911359)

  • 21. Changes in the mitogenic activity of platelet-derived growth factor(s) in patients with myeloproliferative disease.
    Caenazzo A; Pietrogrande F; Polato G; Piva E; Masiero M; Sgarabotto D; Girolami A
    Acta Haematol; 1989; 81(3):131-5. PubMed ID: 2496560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myelofibrosis: a role for platelet derived growth factor (PDGF)?
    Romano M; Poggi A
    Haematologica; 1986; 71(5):359-61. PubMed ID: 3096830
    [No Abstract]   [Full Text] [Related]  

  • 23. Platelet abnormalities in idiopathic myelofibrosis: functional, biochemical and immunomorphological correlations.
    Leoni P; Rupoli S; Lai G; Brunelli MA; Belmonte MM; Pugnaloni A; Rabini RA; Mazzanti L; Biagini G
    Haematologica; 1994; 79(1):29-39. PubMed ID: 15378946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth factor levels in the platelet-rich plasma produced by 2 different methods: curasan-type PRP kit versus PCCS PRP system.
    Weibrich G; Kleis WK; Hafner G
    Int J Oral Maxillofac Implants; 2002; 17(2):184-90. PubMed ID: 11958400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Examination of interleukin levels and growth factor from blood platelets in leukemia].
    Kiersnowska-Rogowska B; Rogowski F; Petelski T; Citko A; Jaroszewicz E; Bielawiec M
    Pol Tyg Lek; 1996 May; 51(19-22):281-2, 288. PubMed ID: 9289710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet-derived growth factor A mRNA in platelets is associated with the degree of hepatic fibrosis in chronic hepatitis C.
    Tanikawa AA; Grotto RM; Silva GF; Ferrasi AC; Sarnighausen VC; Pardini MI
    Rev Soc Bras Med Trop; 2017; 50(1):113-116. PubMed ID: 28327812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pathogenesis of myelofibrosis in myeloproliferative disorders.
    Groopman JE
    Ann Intern Med; 1980 Jun; 92(6):857-8. PubMed ID: 7387029
    [No Abstract]   [Full Text] [Related]  

  • 28. Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia.
    Wang JC; Chang TH; Goldberg A; Novetsky AD; Lichter S; Lipton J
    Exp Hematol; 2006 Dec; 34(12):1617-23. PubMed ID: 17157157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A reversible defect of platelet PDGF content in myeloproliferative disorders.
    Baglin TP; Price SM; Boughton BJ
    Br J Haematol; 1988 Aug; 69(4):483-6. PubMed ID: 3408684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunocytochemical evidence of PDGF- and TGF-beta-like molecules in invertebrate and vertebrate immunocytes: an evolutionary approach.
    Franchini A; Kletsas D; Ottaviani E
    Histochem J; 1996 Sep; 28(9):599-605. PubMed ID: 8910030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of platelet growth factors in supernatants from rehydrated freeze-dried equine platelets and their effects on fibroblasts in vitro.
    Tablin F; Walker NJ; Hogle SE; Pratt SM; Norris JW
    Am J Vet Res; 2008 Nov; 69(11):1512-9. PubMed ID: 18980435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ultrastructural study of platelets in acute myelofibrosis].
    Rozman C; Brugués R
    Sangre (Barc); 1982; 27(6):1030-9. PubMed ID: 6764035
    [No Abstract]   [Full Text] [Related]  

  • 33. Platelets are mitogenic for periosteum-derived cells.
    Gruber R; Karreth F; Frommlet F; Fischer MB; Watzek G
    J Orthop Res; 2003 Sep; 21(5):941-8. PubMed ID: 12919885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous platelet aggregation in myeloproliferative disorders. A preliminary study.
    Barbui T; Battista R; Dini E
    Acta Haematol; 1973; 50(1):25-9. PubMed ID: 4200801
    [No Abstract]   [Full Text] [Related]  

  • 35. Platelet function in variable platelet split products intended for neonatal transfusion.
    Strasser EF; Stachel DK; Schwarzkopf P; Ringwald J; Weisbach V; Zimmermann R; Zingsem J; Eckstein R
    Transfusion; 2006 May; 46(5):757-65. PubMed ID: 16686843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haemostatic defects in myelofibrosis.
    Papayannis AG; Stathakis NE; Economopoulos TC; Arapakis G; Gardikas C
    Acta Haematol; 1974; 51(6):331-8. PubMed ID: 4212048
    [No Abstract]   [Full Text] [Related]  

  • 37. Bilateral interstitial pneumonic shadows caused by perivascular fibrosis and extramedullary megakaryopoiesis of the lung in a case of advanced agnogenic myeloid metaplasia and myelofibrosis.
    Ueno H; Yoneda R; Ogawa W; Yoon S; Kitazawa S; Kitazawa R; Kasuga M
    Acta Haematol; 2000; 104(4):212-6. PubMed ID: 11279314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet-derived growth factor release and antiplatelet treatment with low-dose acetylsalicylic acid.
    Vissinger H; Husted SE; Kristensen SD; Nielsen HK
    Angiology; 1993 Aug; 44(8):633-8. PubMed ID: 8342880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Morphometric analysis of thrombocyte ultrastructure in healthy persons and in patients with acute leukemia, chronic myeloleukosis and myelofibrosis].
    Vashkinel' VK; Petrov MN
    Probl Gematol Pereliv Krovi; 1981 Apr; 26(4):30-3. PubMed ID: 6940116
    [No Abstract]   [Full Text] [Related]  

  • 40. Platelet survival, platelet factor-4 and bleeding time in myeloproliferative disorders.
    Berild D; Hasselbalch H; Knudsen JB
    Scand J Clin Lab Invest; 1987 Sep; 47(5):497-501. PubMed ID: 3477851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.